(Albany, US) Delveinsight has launched a new report on “Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2030.”
DelveInsight’s “Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Cervical Cancer, historical and forecasted epidemiology as well as the Cervical Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts:
Report key Highlights:
Request for Free Sample Report: https://www.delveinsight.com/sample-request/cervical-cancer-market
“As per WHO estimates, Cervical cancer is the fourth most common cancer in women.”
Cervical cancer occurs in the cells of the cervix and usually originates in the transformation zone of the cervix, and spreads to regional lymph nodes with parametrial invasion also common.
Most cases of cervical cancer are caused by infection with human papillomavirus (HPV). Apart from HPV, other factors that can also increase the risk include: human immunodeficiency virus (HIV), chlamydia, smoking, obesity, family history of cervical cancer, diet low in fruits and vegetables, taking birth control pills, and having three full-term pregnancies.
Clinical presentation depends mainly on the location and extent of disease. Precancerous changes or very early stage disease are usually asymptomatic and are detected on a cervical smear. Symptoms usually appear when the tumour causes spontaneous or contact bleeding, or pain if lymph nodes are involved.
Typical cervical cancer symptoms are: unusual bleeding, such as in between periods, after sex, or after menopause, vaginal discharge that looks or smells different than usual, pain in the pelvis, needing to urinate more often, pain during urination etc.
All women are at risk for cervical cancer. It occurs most often in women over age 30. There’s more than one kind of cervical cancer.
Cervical cancer has four stages:
There are 3 different types of screening tests that are currently recommended by WHO;
Some of the key companies:
Drugs Covered:
Table of Contents:
1. Key Insights
2. Executive Summary of Cervical Cancer
3. Competitive Intelligence Analysis for Cervical Cancer
4. Cervical Cancer: Market Overview at a Glance
5. Cervical Cancer: Disease Background and Overview
6. Patient Journey
7. Cervical Cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Cervical Cancer Treatment
11. Marketed Products
12. Emerging Therapies
13. Cervical Cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cervical Cancer
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Detailed TOC: https://www.delveinsight.com/sample-request/cervical-cancer-market
Related Reports:
Cervical Cancer Epidemiology Forecast to 2030
DelveInsight’s ‘Cervical Cancer Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Cervical Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Cervical Cancer Pipeline Insights, 2020
“Cervical Cancer Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cervical Cancer market.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/cervical-cancer-market